🎉 M&A multiples are live!
Check it out!

Solventum Valuation Multiples

Discover revenue and EBITDA valuation multiples for Solventum and similar public comparables like SmartVest, InfuSystem, and Perspective Therapeutics.

Solventum Overview

About Solventum

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.


Founded

2023

HQ

United States of America
Employees

22K+

Website

solventum.com

Financials

LTM Revenue $8.3B

LTM EBITDA $2.1B

EV

$19.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Solventum Financials

Solventum has a last 12-month revenue of $8.3B and a last 12-month EBITDA of $2.1B.

In the most recent fiscal year, Solventum achieved revenue of $8.3B and an EBITDA of $1.5B.

Solventum expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Solventum valuation multiples based on analyst estimates

Solventum P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $8.2B $8.3B XXX XXX XXX
Gross Profit $4.6B $4.6B XXX XXX XXX
Gross Margin 55% 55% XXX XXX XXX
EBITDA $2.0B $1.5B XXX XXX XXX
EBITDA Margin 25% 19% XXX XXX XXX
Net Profit $720M $692M XXX XXX XXX
Net Margin 9% 8% XXX XXX XXX
Net Debt n/a $7.7B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Solventum Stock Performance

As of April 15, 2025, Solventum's stock price is $68.

Solventum has current market cap of $11.7B, and EV of $19.0B.

See Solventum trading valuation data

Solventum Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$19.0B $11.7B XXX XXX XXX XXX $6.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Solventum Valuation Multiples

As of April 15, 2025, Solventum has market cap of $11.7B and EV of $19.0B.

Solventum's trades at 2.3x LTM EV/Revenue multiple, and 9.2x LTM EBITDA.

Analysts estimate Solventum's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Solventum and 10K+ public comps

Solventum Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $19.0B XXX XXX XXX
EV/Revenue 2.3x XXX XXX XXX
EV/EBITDA 12.4x XXX XXX XXX
P/E 24.5x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF 23.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Solventum Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Solventum Valuation Multiples

Solventum's NTM/LTM revenue growth is 0%

Solventum's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Solventum's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Solventum's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Solventum and other 10K+ public comps

Solventum Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 19% XXX XXX XXX XXX
EBITDA Growth -25% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 18% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 9% XXX XXX XXX XXX
Opex to Revenue 43% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Solventum Public Comps

See public comps and valuation multiples for Medical Devices and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Solventum M&A and Investment Activity

Solventum acquired  XXX companies to date.

Last acquisition by Solventum was  XXXXXXXX, XXXXX XXXXX XXXXXX . Solventum acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Solventum

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Solventum

When was Solventum founded? Solventum was founded in 2023.
Where is Solventum headquartered? Solventum is headquartered in United States of America.
How many employees does Solventum have? As of today, Solventum has 22K+ employees.
Who is the CEO of Solventum? Solventum's CEO is Mr. Bryan C. Hanson.
Is Solventum publicy listed? Yes, Solventum is a public company listed on NYS.
What is the stock symbol of Solventum? Solventum trades under SOLV ticker.
When did Solventum go public? Solventum went public in 2024.
Who are competitors of Solventum? Similar companies to Solventum include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Solventum? Solventum's current market cap is $11.7B
What is the current revenue of Solventum? Solventum's last 12-month revenue is $8.3B.
What is the current EBITDA of Solventum? Solventum's last 12-month EBITDA is $2.1B.
What is the current EV/Revenue multiple of Solventum? Current revenue multiple of Solventum is 2.3x.
What is the current EV/EBITDA multiple of Solventum? Current EBITDA multiple of Solventum is 9.2x.
What is the current revenue growth of Solventum? Solventum revenue growth between 2023 and 2024 was 0%.
Is Solventum profitable? Yes, Solventum is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.